October 1, 2018

Entegrion, Inc.

Developer of biologic and medical device technologies for wound management designed to improve the safety and availability of human blood supply. The company's biologic and medical device technologies work through pharmaceutical agents that offer enhanced safety and equivalent efficacy for transfusion recipients through the reduction of non-enveloped viruses and elimination of pro-inflammatory factors that can lead to morbidity and mortality, enabling doctors to address the unmet needs in military healthcare involving wound management, tissue repair and hemorrhage control.